These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 36426837

  • 1. Objectively quantifying facial erythema in rosacea aided by the ImageJ analysis of VISIA red images.
    Tao M, Li M, Zhang Y, Liu Y, Jiang P, Liu Y, Xu Y.
    Skin Res Technol; 2023 Jan; 29(1):e13241. PubMed ID: 36426837
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of VISIA system in evaluating the severity of rosacea.
    Pan Y, Jia K, Yan S, Jiang X.
    Skin Res Technol; 2022 Sep; 28(5):740-748. PubMed ID: 35818722
    [Abstract] [Full Text] [Related]

  • 3. Quantifying facial skin erythema more precisely by analyzing color channels of The VISIA Red images.
    Xu DT, Yan JN, Cui Y, Liu W.
    J Cosmet Laser Ther; 2016 Oct; 18(5):296-300. PubMed ID: 26980669
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatment.
    Logger JGM, de Jong EMGJ, Driessen RJB, van Erp PEJ.
    Skin Res Technol; 2020 Nov; 26(6):804-812. PubMed ID: 32537843
    [Abstract] [Full Text] [Related]

  • 5. Relationship Between Dermoscopic Capillary-Related Features of the Auricle and Earlobe and Rosacea Subtype and Disease Severity: A Cross-Sectional Analysis.
    Zhang Y, Pan R, Gu D, Meng X, Liu T, Xu Y.
    Clin Cosmet Investig Dermatol; 2023 Nov; 16():3221-3228. PubMed ID: 37965100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity.
    Wienholtz NKF, Thyssen JP, Christensen CE, Thomsen SF, Karmisholt KE, Jemec GBE, Lomholt HB, Heidenheim M, Simonsen AB, Sand C, Vestergaard C, Kaur-Knudsen D, Ammitzbøll E, Lørup E, Danielsen AG, Strauss G, Skov L, Andersen PH, Hald M, Idorn LW, Ashina M, Zachariae C, Egeberg A.
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):573-580. PubMed ID: 36331365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reliability of Clinician Erythema Assessment grading scale.
    Tan J, Liu H, Leyden JJ, Leoni MJ.
    J Am Acad Dermatol; 2014 Oct; 71(4):760-3. PubMed ID: 24999270
    [Abstract] [Full Text] [Related]

  • 11. Analysis of facial redness by comparing VISIA® from Canfield and CSKIN® from Yanyun Technology.
    Chen Y, Hua W, Li A, He H, Xie L, Li L.
    Skin Res Technol; 2020 Sep; 26(5):696-701. PubMed ID: 32196761
    [Abstract] [Full Text] [Related]

  • 12. The relationship between the distribution of facial erythema and skin type in rosacea patients: a cross-sectional analysis.
    Tao M, Li M, Zhang Y, Gu D, Pan R, Xu Y.
    Arch Dermatol Res; 2023 Sep; 315(7):2179-2182. PubMed ID: 36939880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L, Goldberg DJ, Stein Gold L, Tanghetti EA, Lain E, Kaufman J, Weng E, Berk DR, Ahluwalia G.
    J Drugs Dermatol; 2018 Mar 01; 17(3):290-298. PubMed ID: 29537447
    [Abstract] [Full Text] [Related]

  • 15. Facial flushing and erythema of rosacea improved by carvedilol.
    Seo BH, Kim DH, Suh HS, Choi YS.
    Dermatol Ther; 2020 Nov 01; 33(6):e14520. PubMed ID: 33174351
    [Abstract] [Full Text] [Related]

  • 16. Analysis of facial redness by comparing VISIA and YLGTD.
    Ma L, Huang X, Qiu Y, He Y.
    Skin Res Technol; 2023 Jul 01; 29(7):e13356. PubMed ID: 37522504
    [Abstract] [Full Text] [Related]

  • 17. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH, DuBois J, Draelos ZD, Werschler P, Grande K, Cook-Bolden FE, Weng E, Berk DR, Ahluwalia G.
    J Drugs Dermatol; 2018 Jan 01; 17(1):97-105. PubMed ID: 29320594
    [Abstract] [Full Text] [Related]

  • 18. Clinical assessment of rosacea severity: oriental score vs. quantitative assessment method with imaging and biomedical tools.
    Kim J, Ahn JW, Ha S, Kwon SH, Lee O, Oh C.
    Skin Res Technol; 2017 May 01; 23(2):186-193. PubMed ID: 27514310
    [Abstract] [Full Text] [Related]

  • 19. Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.
    Liu T, Li J, Deng Z, Chen M, Sha K, Xiao W, Xie H, Zhao Z.
    J Dermatol; 2022 May 01; 49(5):525-533. PubMed ID: 35233832
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness and safety of once-daily doxycycline capsules as monotherapy in patients with rosacea: an analysis by Fitzpatrick skin type.
    Alexis AF, Webster G, Preston NJ, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2012 Oct 01; 11(10):1219-22. PubMed ID: 23134987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.